Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 223 entries
View as:

Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01513681 Org: User:
Start: 11/30/02 End: 11/30/02 Due: 11/30/03

Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01581788 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01512459 Org: User:
Start: 05/31/06 End: 06/30/06 Due: 06/30/07

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01372982 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT02295046 Org: User:
Start: 10/31/11 End: 11/30/11 Due: 11/30/12

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

Phase: N/A Priority: Normal
NCT ID: NCT01314339 Org: User:
Start: 12/31/05 End: 02/28/06 Due: 02/28/07

Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01923259 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03341910 Org: User:
Start: 08/21/17 End: 05/18/18 Due: 05/18/19

Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01136538 Org: User:
Start: 02/28/07 End: 05/31/07 Due: 05/31/08

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01503450 Org: User:
Start: 11/30/06 End: 12/31/06 Due: 12/31/07

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01166100 Org: User:
Start: 02/28/06 End: 08/31/06 Due: 08/31/07

Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01155934 Org: User:
Start: 08/31/04 End: 08/31/04 Due: 08/31/05

Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01170182 Org: User:
Start: 02/28/06 End: 04/30/06 Due: 04/30/07

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01160068 Org: User:
Start: 02/28/05 End: 05/31/05 Due: 05/31/06

Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01512485 Org: User:
Start: 10/31/06 End: 10/31/06 Due: 10/31/07

Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02322645 Org: User:
Start: 08/31/08 End: 10/31/08 Due: 10/31/09

A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules

Phase: N/A Priority: Normal
NCT ID: NCT03340961 Org: User:
Start: 10/01/17 End: 03/31/19 Due: 03/31/20

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01155947 Org: User:
Start: 05/31/08 End: 07/31/08 Due: 07/31/09

Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03282838 Org: User:
Start: 06/09/17 End: 01/12/18 Due: 01/12/19

Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01053338 Org: User:
Start: 04/30/08 End: 04/30/08 Due: 04/30/09

A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02173301 Org: User:
Start: 06/30/14 End: 08/31/15 Due: 08/31/16

Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01066754 Org: User:
Start: 04/30/02 End: 05/31/02 Due: 05/31/03

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01146067 Org: User:
Start: 01/31/04 End: 02/29/04 Due: 02/28/05

Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01053208 Org: User:
Start: 04/30/08 End: 04/30/08 Due: 04/30/09

Ketorol Gel in Gonarthrosis and Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT02638831 Org: User:
Start: 03/31/13 End: 11/30/13 Due: 11/30/14